Skandinaviska Enskilda Banken AB (publ) - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2022$104,000
-41.6%
6,6030.0%0.00%0.0%
Q1 2022$178,000
-30.7%
6,6030.0%0.00%0.0%
Q4 2021$257,000
-18.4%
6,6030.0%0.00%
-50.0%
Q3 2021$315,000
-63.1%
6,603
-73.8%
0.00%
-60.0%
Q2 2021$853,00025,2170.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders